Ovrebø K K, Sørbye H, Kvinnsland S, Grong K, Svanes K
Department of Surgery, University of Bergen, Haukeland Hospital, Norway.
Dig Dis Sci. 1998 Sep;43(9):2012-20. doi: 10.1023/a:1018898928870.
Clinical conditions with low gastric acid secretion have been associated with increased risk of gastric cancer. There has also been concern about gastric acid inhibition and N-nitroso compound formation in the stomach. This study investigates the effect of gastric acid secretion on the penetration of N-3H-methyl-N-nitro-N-nitrosoguanidine, an N-nitroso compound and gastric carcinogen, into the gastric mucosa of rats. Gastric acid secretion was stimulated by pentagastrin (40 microg/kg/hr) and inhibited by omeprazole (40 micromol/kg) before mucosal exposure to N-3H-methyl-N-nitro-N-nitrosoguanidine. Penetration of the carcinogen was evaluated by light microscopic identification of cells in the S-phase labeled with N-3H-methyl-N-nitro-N-nitrosoguanidine. This population of double-labeled cells is considered at risk from N-methyl-N-nitro-N-nitrosoguanidine-induced carcinogenesis. The percentage of double-labeled cells was significantly higher in antrum than in corpus mucosa (P < 0.0001). Stimulation or inhibition of gastric acid secretion did not affect the penetration of N-3H-methyl-N-nitro-N-nitrosoguanidine in antrum or corpus mucosa. We conclude that modulation of gastric acid secretion does not affect the penetration of the carcinogen into the gastric mucosa nor does it explain the different penetration of the carcinogen into corpus and antrum mucosa.
胃酸分泌较低的临床状况与胃癌风险增加有关。人们也一直担心胃酸抑制以及胃内N - 亚硝基化合物的形成。本研究调查胃酸分泌对N - 3H - 甲基 - N - 硝基 - N - 亚硝基胍(一种N - 亚硝基化合物和胃致癌物)渗透到大鼠胃黏膜中的影响。在胃黏膜暴露于N - 3H - 甲基 - N - 硝基 - N - 亚硝基胍之前,用五肽胃泌素(40微克/千克/小时)刺激胃酸分泌,并用奥美拉唑(40微摩尔/千克)抑制胃酸分泌。通过光学显微镜鉴定用N - 3H - 甲基 - N - 硝基 - N - 亚硝基胍标记的S期细胞来评估致癌物的渗透情况。这群双标记细胞被认为有受N - 甲基 - N - 硝基 - N - 亚硝基胍诱导致癌的风险。胃窦部双标记细胞的百分比显著高于胃体黏膜(P < 0.0001)。刺激或抑制胃酸分泌均不影响N - 3H - 甲基 - N - 硝基 - N - 亚硝基胍在胃窦部或胃体黏膜中的渗透。我们得出结论,胃酸分泌的调节不影响致癌物渗透到胃黏膜中,也无法解释致癌物在胃体和胃窦黏膜中不同的渗透情况。